COMMUNIQUÉS West-GlobeNewswire

Sienna Biopharmaceuticals Reports Second Quarter 2018 Financial Results

09/08/2018 - 15:05

WESTLAKE VILLAGE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA), a clinical-stage medical dermatology and aesthetics company, today reported the Company’s financial results for [...]

Medtronic Begins Pilot Study of Investigational Extravascular ICD System

09/08/2018 - 15:01

Chronic Study Evaluating New ICD System Designed to Deliver Pacing and Defibrillation Therapy Via a Lead Placed Under the Sternum, Outside the Heart and Veins DUBLIN - August 9, 2018 - Medtronic plc (NYSE:MDT) today [...]

Aptevo Therapeutics Reports Second Quarter 2018 Financial Results

09/08/2018 - 15:00

Achieves Record IXINITY ® Net Revenue with 94% Increase in Year-Over-Year Quarterly Revenue Publishes and Presents New Data on Multiple ADAPTIR™ Bispecific Candidates Showing Robust Immune System Engagement and T-cell [...]

BioStem Technologies, Inc. (BSEM) Launches New Subsidiary to Engage in the Processing and Supply of Regenerative Tissue Products

09/08/2018 - 15:00

Pompano Beach, FL, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), BioStem Technologies, Inc. is a global life sciences corporation, providing innovative [...]

Athenex Pharmaceutical Division Receives FDA Clearance to Import Potassium Chloride Injection Concentrate to Address U.S. Drug Shortage

09/08/2018 - 15:00

BUFFALO, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 8 August 2018

09/08/2018 - 14:38

Bagsværd, Denmark, 9 August 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article 19 [...]

Precision Therapeutics Investee, Helomics Corporation, Launches Precision Oncology Insights Platform

09/08/2018 - 14:30

MINNEAPOLIS, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]

PolarityTE, Inc. Announces the Addition of Ramses Erdtmann, Managing Partner at Point Sur Investors and Former Executive at Pharmacyclics, and David Seaburg, Managing Director at Cowen and CNBC Contributor, to the Board of Directors

09/08/2018 - 14:30

SALT LAKE CITY, Aug. 09, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL), a commercial-stage biotechnology and regenerative biomaterials company focused on transforming the lives of patients by discovering, [...]

Arbutus to Present at the 2018 Wedbush PacGrow Healthcare Conference

09/08/2018 - 14:30

WARMINSTER, Pa., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia, Arbutus [...]

Fluidigm to Host 2nd Annual Imaging Mass Cytometry User Group Meeting

09/08/2018 - 14:30

Leading translational and clinical researchers to share new insights and best practices using Imaging Mass Cytometry SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass [...]

Pressure BioSciences, Inc. President and CEO, Richard T. Schumacher, Discusses Recent Company Achievements with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast

09/08/2018 - 14:30

PHOENIX, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Uptick Newswire today announced the release of an interview with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (the “Company”) on Uptick [...]

Auris Medical to Report Second Quarter 2018 Financial Results and Provide Business and Update on Wednesday, August 15, 2018

09/08/2018 - 14:01

Zug, Switzerland, August 09, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]

Portola Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

09/08/2018 - 14:01

– Conference Call Today at 8:30 a.m. ET – SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today reported financial results for the three months ended June 30 [...]

AVROBIO, Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

09/08/2018 - 14:00

Completes IPO, initiates Phase 2 clinical trial in Fabry disease, expands board of directors CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical stage [...]

Stemline Therapeutics Reports Second Quarter 2018 Financial Results

09/08/2018 - 14:00

NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, announced today its financial results for the [...]

NuLife Announces Merger Agreement with Two Louisiana Electronic Security Firms

09/08/2018 - 14:00

NEWPORT BEACH, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- NuLife Sciences, Inc. (OTCQB: “NULF”) announced today that it has entered into a definitive merger agreement to acquire LJR Security Services, Inc. (“LJR”) and [...]

Key Biologics and Astarte Biologics Merge

09/08/2018 - 14:00

Includes growth equity investment from Ampersand Capital Partners MEMPHIS, Tenn. and BOTHELL, Wash., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Key Biologics , has completed its merger with Astarte Biologics to create the [...]

Nemaura Medical Inc. Reports First Quarter 2018 Financial Results

09/08/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today reported [...]

electroCore, Inc. Announces Research Collaboration with Massachusetts General Hospital to Explore Non-Invasive Vagus Nerve Stimulation in Neuroinflammation

09/08/2018 - 14:00

BASKING RIDGE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced a research collaboration with Massachusetts General Hospital ( [...]